Bausch Health Companies (BHC) Gross Margin Growth (3y) (2012 - 2026)
Bausch Health Companies (BHC) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | 313.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 313.00 |
| Mar 31, 2026 | 2,942.00 |
| Dec 31, 2025 | -7,450.00 |
| Sep 30, 2025 | 2,748.00 |
| Jun 30, 2025 | 2,757.00 |
| Mar 31, 2025 | 2,790.00 |
| Dec 31, 2024 | -2,060.00 |
| Sep 30, 2024 | 2,269.00 |
| Jun 30, 2024 | 38.00 |
| Mar 31, 2024 | 49.00 |
| Dec 31, 2023 | -6,735.00 |
| Sep 30, 2023 | -2,678.00 |
| Jun 30, 2023 | -2,875.00 |
| Mar 31, 2023 | -2,873.00 |
| Dec 31, 2022 | 171.00 |
| Sep 30, 2022 | -2,742.00 |
| Jun 30, 2022 | -192.00 |
| Mar 31, 2022 | -2,730.00 |
| Dec 31, 2021 | -5,552.00 |
| Sep 30, 2021 | -2,677.00 |